Early Safety Profile of Merigrow Mesh in Elective Hernia Repair: A 12-Month Retrospective Analysis

Background: Polypropylene meshes are widely used in hernia repair, with design and placement techniques significantly impacting postoperative outcomes.Merigrow Mesh is a microporous, lightweight polypropylene mesh that improves tissue integration while minimizing complications such as seroma, chronic pain and surgical site infections (SSI).This study evaluated its safety profile under real-world surgical conditions.Aim: To evaluate Merigrow Mesh safety and performance in elective hernia repair patients in a retrospective observational study.Methodology: A total of 119 patients underwent elective hernia repair with Merigrow Mesh, with different mesh placement techniques.Standardized suture fixation was used in all cases.Patients were followed up to 12 months to assess early post-market safety outcomes, including complications and preliminary recurrence signals.Follow-up data were captured up to 12 months to assess early safety outcomes.Results: A total of 119 patients, with a mean age of 49.0213.98years and predominantly male (84.87%), were enrolled in the study.The average surgical duration was 68.0734.72 minutes.The SSI rate at 7 days was 1.68%, while seroma incidence was 3.36% of total cases.The highest seroma incidence (14.29 %) not statistically significant).No mesh migration, recurrence, or chronic postoperative pain occurred.All procedures were completed without intraoperative complications.Conclusion: Merigrow Mesh establishes a favourable safety profile in elective hernia repair, with low rates of SSI, seroma, and no recurrence.Findings support its early postmarket safety, though long-term recurrence trends require further study.